Today

Agents

Chat

Arena

Discover

More

App

Fennec Pharmaceuticals schedules second-quarter 2026 results call - FENC News | Rallies

Fennec Pharmaceuticals schedules second-quarter 2026 results call

FENC•2026-08-05

Second-quarter results call scheduled

Fennec Pharmaceuticals will release second-quarter 2026 financial results before the U.S. market open on Aug. 11, 2026.
Management will host a conference call at 8:30 a.m. ET on Aug. 11, 2026, with a webcast at https://edge.media-server.com/mmc/p/tjdvggzn.

Related News

TransMedics Group, Inc. <TMDX.O>: UBS cuts target price to $77 from $80

TMDX•2026-08-05

Popular declares $0.13 monthly dividend on 6.375% preferred stock

BPOP•2026-08-05

Revolve Group Inc <RVLV.N>: UBS raises target price to $29 from $28

2026-08-05

Expeditors International of Washington Inc <EXPD.N>: UBS raises target price to $210 from $191

EXPD•2026-08-05

BeOne Medicines publishes Q2 clinical trials portfolio presentation detailing pipeline and study updates

ONC•2026-08-05